Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2005 1
2006 3
2007 2
2008 2
2011 1
2012 2
2013 1
2014 2
2017 1
2018 1
2019 1
2020 2
2021 3
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities.
Hubesch G, Hanthazi A, Acheampong A, Chomette L, Lasolle H, Hupkens E, Jespers P, Vegh G, Wembonyama CWM, Verhoeven C, Dewachter C, Vachiery JL, Entee KM, Dewachter L. Hubesch G, et al. Among authors: jespers p. Front Cardiovasc Med. 2022 Jan 13;8:809885. doi: 10.3389/fcvm.2021.809885. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35097026 Free PMC article.
Exploratory analysis of tumor imaging in a Phase 2 trial with cabozantinib in gastrointestinal stromal tumor: lessons learned from study EORTC STBSG 1317 'CaboGIST'.
Kyriazoglou A, Jespers P, Vandecavaye V, Mir O, Kasper B, Papai Z, Blay JY, Italiano A, Zaffaroni F, Litière S, Nzokirantevye A, Schöffski P. Kyriazoglou A, et al. Among authors: jespers p. Acta Oncol. 2022 Jun;61(6):663-668. doi: 10.1080/0284186X.2022.2068967. Epub 2022 Apr 28. Acta Oncol. 2022. PMID: 35481400 Clinical Trial.
Detection of soluble suppression of tumorigenicity 2 and N-terminal B-type natriuretic peptide in a rat model of aortic regurgitation: differential responses to omecamtiv mecarbil.
El Oumeiri B, van de Borne P, Hubesch G, Jespers P, Dewachter L, Stefanidis C, Mc Entee K, Vanden Eynden F. El Oumeiri B, et al. Among authors: jespers p. J Basic Clin Physiol Pharmacol. 2022 Oct 10;33(6):743-750. doi: 10.1515/jbcpp-2022-0215. eCollection 2022 Nov 1. J Basic Clin Physiol Pharmacol. 2022. PMID: 36215707
23 results